We are saddened to learn of the passing of Alan Scott MD, world-famous ophthalmologist and researcher who spent much of his career at Smith-Kettlewell including serving for many years as its Co-Director and Director and working closely with Founder and President of the Board, Dr Arthur Jampolsky. He is most well-known for his pioneering research into the use of botulinum toxin to modify the characteristics of eye muscles, as a relatively non-invasive alternative to surgery in the treatment of strabismus or crossed eyes. This invention was taken over by Allergan and renamed “Botox”, with its applications in many other fields of medicine, helping millions of people around the world.
All of us at Smith-Kettlewell extend sympathy to his family and friends throughout the world in this time of such a sad loss.
For more information about Dr. Scott's life and career:
Alan Scott, the doctor credited with developing Botox for medicine, dies at 89
Alan Scott, researcher who pioneered medical uses of Botox, dies at 89